Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1

BACKGROUND: Previous studies using pegylated interferon (Peg-IFN) and ribavirin (RBV) combination therapy suggested that patients with hepatitis C virus (HCV) genotype 1 and low pretreatment HCV RNA level who achieved rapid virological response (RVR) can be treated for 24 weeks without compromising...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharafi, Heidar, Alavian, Seyed Moayed, Keshvari, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330713/
https://www.ncbi.nlm.nih.gov/pubmed/25741374
http://dx.doi.org/10.5812/hepatmon.24955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330713/
https://www.ncbi.nlm.nih.gov/pubmed/25741374
http://dx.doi.org/10.5812/hepatmon.24955

Ejemplares similares